Inducible nitric oxide synthase-mediated proliferation of a T lymphoma cell line

Nitric Oxide - Biology and Chemistry

Volumn 8, Issue 2, 2003, Pages 111-118

  Barreiro Arcos, Maria Laura ^a   Gorelik, Gabriela ^a   Klecha, Alicia ^a   Goren, Nora ^a   Cerquetti, Cristina ^a   Cremaschi, Graciela A ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

iNOS; Nitric oxide synthase; Proliferation; T lymphocytes; T lymphoma cell line

Indexed keywords

AMINOGUANIDINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHELATING AGENT; DIPHENYLIODONIUM SALT; EGTAZIC ACID; GENISTEIN; METHYLISOTHIOUREA; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; STAUROSPORINE; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; LYMPHOMA CELL LINE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LYMPHOMA;

EID: 0037334139     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-8603(02)00181-7     Document Type: Article

References (35)

1. Moncada S., Higgs A., Furchgott R. XIVth International union of pharmacology nomenclature in nitric oxide research. Pharmacol. Rev. 49:1997;137-142.
2. Stuehr D.J., Nathan C.F. Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1989;1543-1545.
3. Nathan C.F., Hibbs J.B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:1991;65-70.
4. Bonham C.A., Lu L., Li Y., Hoffman R.A., Simmons R.L., Thomson A.W. Nitric oxide production by mouse bone marrow-derived dendritic cells: Implications for the regulation of allogeneic T cell responses. Transplantation. 62:1996;1871-1877.
5. Albina J.E., Cui S., Mateo R.B., Reichner J.S. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150:1993;5080-5085.
6. Hoffman R.A., Langrehr J.M., Wren S.M., Dull K.E., Ildstad S.T., McCarthy S.A., Simmons R.L. Characterization of the immunosuppresive effects of nitric oxide in graft vs host disease. J. Immunol. 151:1993;1508-1518.
7. Liew F.Y. Regulation of lymphocyte functions by nitric oxide. Curr. Opin. Immunol. 7:1995;396-399.
8. Taylor-Robinson A.W., Liew F.Y., Severn A., Xu D., McSorley S.J., Garside P., Padron J., Phillips R.S. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24:1994;980-984.
9. 2+/calmodulin-dependent isoform in human B and T lymphocytes Eur. J. Immunol. 26:1996;511-516.
10. Sciorati C., Rovere P., Ferrarini M., Heltai S., Manfredi A.A., Clementi E. Autocrine nitric oxide modulates CD95-induced apoptosis in. γδ T lymphocytes J. Biol. Chem. 272:1997;23211-23215.
11. Williams M.S., Noguchi S., Henkart P.A., Osawa Y. Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. J. Immunol. 161:1998;6526-6531.
12. Mannick J.B., Asano K., Izumi K., Kieff E., Stamler J.S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 79:1994;1137-1146.
13. Murphy P.R., Limoges M., Dodd F., Boudreau R.T., Too C.K. Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric oxide-dependent pathway in Nb2 lymphoma cells. Endocrinology. 142:2001;81-88.
14. Cazaux C.A., Sterin-Borda L., Gorelik G., Cremaschi G.A. Down regulation of β adrenergic receptors induced by mitogen activation of intracellular signalling events in lymphocytes. FEBS Lett. 364:1995;120-124.
15. Genaro A.M., Borda E., Cremaschi G.A., Sterin-Borda L., Braun M. H-2 specific inotropic effect of alloimmune lymphoid cells on mouse isolated atria. Immunopharmacology. 11:1986;129-140.
16. Hortelano S., Genaro A.M., Boscá L. Phorbol esters induce nitric oxide synthase and increase arginine influx in cultured peritoneal macrophages. FEBS Lett. 320:1993;135-139.
17. Granger D.L., Hidds J.B., Perfect J.R., Durack D.T. Metabolic fate of L-arginine inhalation to microbiostatic capability of murine macrophages. J. Clin. Invest. 85:1990;264-273.
18. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
19. Goren N., Sterin-Borda L., Bartrons R., Gomez R., Borda E. Detection of mRNA encoding H1 receptor and iNOS by RT-PCR in autoimmune myocarditis with special reference to changes in heart contractility. Int. J. Cardiol. 76:2000;165-172.
20. Lowenstein C.J., Glatt C.S., Bredt D.S., Snyder S.H. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA. 89:1992;6711-6715.
21. Sciorati C., Nistico G., Meldolesi J., Clementi E. Nitric oxide effects on cell growth: GMP-dependent stimulation or the AP-1 transcription complex and cyclic GMP-independent slowing of cell cycling. Br. J. Pharmcol. 122:1997;687-697.
22. Hoffman R.A., Langrehr J.M., Billiar T.R., Curran R.D., Simmons R.L. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J. Immunol. 145:1990;2220-2226.
23. Ianaro A., O'Donnell C.A., Di Rosa M., Liew F.Y. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances IL-10 production in carrageenin-induced oedema in mice. Immunology. 82:1994;370-375.
24. Effron D.T., Kirk S.J., Regan M.C., Wasserkrug H.L., Barbul A. Nitric oxide generation from L-arginine is required for optimal human peripheral blood lymphocyte DNA synthesis. Surgery. 110:1991;327-334.
25. Ziche M., Morbidelli L., Masini E., Amerini S., Granger H.J., Maggi C.A., Geppetti P., Ledda F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vivo promoted by substance P. J. Clin. Invest. 94:1994;2036-2044.
26. Muñoz-Fernández M.A., Fresno M. Involvement of nitric oxide on the cytokine induced growth of glial cells. Biochem. Biophys. Res. Commun. 194:1993;319-325.
27. Dodd F., Limoges M., Boudreau R.T., Rowden G., Murphy P.R., Too C.K. L-Arginine inhibits apoptosis via a NO-dependent mechanism in Nb2 lymphoma cells. J. Cell Biochem. 77:2000;624-634.
28. Gouyao W.U. Arginine metabolism: Nitric oxide and beyond. Biochem. J. 336:1998;1-17.
29. Zanker B., Marx S., Strom T.B., Kohler H. The immunosuppresive effects of verapamil upon mitogen activated and allo-antigen inducible human cytotoxic T-lymphocytes. Int. J. Immunopharmacol. 16:1994;507-517.
30. Szabó C., Southanm G.J., Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 91:1994;12472-12476.
31. O'Donnell V.B., Tew D.G., Jones O.T.G., England P.J. Studies on the inhibitory mechanism of iodoniium compounds with special reference to neutrophil NADPH oxidase. Biochem. J. 290:1993;41-49.
32. Sonic T., Matsuzaki H., Nagasaki A., Hata H., Yoshida M., Matsuoka M., Kuribayashi N., Kimura T., Harada N., Takatsuki K., Mitsuya H., Mori M. Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: Clinical features and apoptosis by NOS inhibitor. Leukemia. 13:1999;713-718.
33. Mori N., Nunokawa Y., Yamada Y., Ikeda S., Tomonaga M., Yamamoto N. Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells. Blood. 94:1999;2862-2870.
34. Zhao H., Dugas N., Mathiot C., Delmer A., Dugas B., Sigaux F., Kolb J.P. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. Blood. 92:1998;1031-1043.
35. Mendes R.V., Martins A.R., de Nucci G., Murad F., Soares F.A. Expression of nitric oxide synthase isoforms and nitrotyrosine immunoreactivity by B-cell non-Hodgkin's lymphomas and multiple myeloma. Histopathology. 39:2001;172-178.